REal-World Analyses of Stroke - Thrombus Occlusion REtrieval
Sponsor: Microvention-Terumo, Inc.
Listed as NCT04451525, this observational or N/A phase trial focuses on Acute Ischemic Stroke and Ischemic and remains completed. Sponsored by Microvention-Terumo, Inc., it has been updated 21 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Jul 2025 — Sep 2025 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2025 — Jul 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2024 — Mar 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
▶ Show 16 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
-
Dec 2023 — Jan 2024 [monthly]
Recruiting
-
Nov 2023 — Dec 2023 [monthly]
Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Recruiting
-
May 2023 — Oct 2023 [monthly]
Recruiting
-
Mar 2023 — May 2023 [monthly]
Recruiting
-
Dec 2022 — Mar 2023 [monthly]
Recruiting
-
Sep 2022 — Dec 2022 [monthly]
Recruiting
-
May 2022 — Sep 2022 [monthly]
Recruiting
-
Apr 2022 — May 2022 [monthly]
Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Recruiting
-
Sep 2021 — Mar 2022 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Oct 2020 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Microvention-Terumo, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Augusta, United States, Baltimore, United States, Boston, United States, Bridgeton, United States, Burbank, United States, Carmel, United States, Carmichael, United States, Cincinnati, United States, Cleveland, United States, Colorado Springs, United States and 27 more location s